Dr. Jason Wiesner

Practice Management
Remote reading prepares group for COVID-19 response
When a radiology group in Northern California "took back the night" by insourcing its overnight teleradiology image interpretation several years ago, it had no idea it was also preparing itself for a more effective response to the COVID-19 pandemic. Dr. Jason Wiesner of Sutter Health explains.
May 31, 2020
2019 11 07 19 53 4087 Doctor Monitor Triple 400
Page 1 of 1
Top Stories
Moscone Center Astro
Radiation Oncology/Therapy
ASTRO: Contemporary IMRT comparable to proton therapy for throat cancer
Phase III U.K. TORPEdO trial investigated proton beam therapy for reducing long-term treatment-related toxicities.
Survey Form 400
Practice Management
NAPT survey results show promise for proton therapy
Moscone Center Astro
Radiation Oncology/Therapy
ASTRO: Low-dose RT effective for treating knee osteoarthritis
Moscone Center Astro
Radiation Oncology/Therapy
ASTRO: Genomic test predicts benefit of hormone therapy in prostate cancer
Digital Innovations Shaping the Future of Radiology
Sponsor Content
Digital Innovations Shaping the Future of Radiology
More in Home
ASTRO: Contemporary IMRT comparable to proton therapy for throat cancer
By Liz Carey
Phase III U.K. TORPEdO trial investigated proton beam therapy for reducing long-term treatment-related toxicities.
September 29, 2025
Moscone Center Astro
NAPT survey results show promise for proton therapy
By Amerigo Allegretto
Proton therapy continues to experience increased clinical use, but barriers to care continue to limit its potential.
September 29, 2025
Survey Form 400
ASTRO: Low-dose RT effective for treating knee osteoarthritis
By Amerigo Allegretto
Research presented at ASTRO 2025 showed the effectiveness of low-dose radiation therapy for treating knee osteoarthritis.
September 29, 2025
Moscone Center Astro
ASTRO: Genomic test predicts benefit of hormone therapy in prostate cancer
By Will Morton
Patients with a prostate tumor subtype known as luminal B had meaningful benefits from the addition of apalutamide to secondary radiotherapy.
September 29, 2025
Moscone Center Astro
ASTRO: Patient navigation key to mitigating RT treatment disparities
By Kate Madden Yee
"Patients are lost and need to be navigated," said presenter Christina Chapman, MD, of Baylor College of Medicine in Houston.
September 29, 2025
Moscone Center Astro
ASTRO: Radiotherapy offers opportunities beyond cancer treatment
By Kate Madden Yee
Radiotherapy isn't just for cancer treatment, according to talks at ASTRO 2025 in San Francisco.
September 28, 2025
Moscone Center Astro
Case report: Pluvicto as a first-line treatment in late-stage prostate cancer
Since 1996, the patient continually declined androgen deprivation therapy, chemotherapy, and local therapy to the prostate gland.
September 26, 2025
Burden of PSMA-expressing prostate cancer before and after treatment with two cycles of Lu-177 PSMA-617. (A and B) Reduction in overall disease burden is evident after treatment. Avidity of patient’s primary prostate tumor and his osseous metastasis shown before (C) and after (D) treatment.
New brain MRI imaging technique could help identify Alzheimer's
By Kate Madden Yee
Researchers used 7-tesla MRI to demonstrate how microvessel pulses in the brain's deep white matter increase with age.
September 26, 2025
Mri Head
Scholarly activity low among residency program directors
By Amerigo Allegretto
Study results point toward program directors focusing on administrative responsibilities rather than scholarly activity.
September 26, 2025
Research Highlighter Res
3D DEXA shows value in patients with prostate cancer
By Will Morton
3D DEXA may be a practical and valuable tool for detecting structural bone changes in prostate cancer patients.
September 25, 2025
Dexa
Smith-Bindman unpacks NEJM pediatric CT study
By Kate Madden Yee
In a video interview, the researcher acknowledged CT's importance to patient care but advocated for its appropriate use.
September 25, 2025
Rebecca Smith-Bindman, MD
Women who skip first mammogram more likely to die of breast cancer
By Amerigo Allegretto
Women who do not participate in their first breast cancer screening are 40% more likely to die later from the disease.
September 24, 2025
Mammography Breast Ipad Patient 400
Page 1 of 173
Next Page